IDH1 and central nervous system cancer: Glycolytic flux is reduced in IDH1 mutant glioma tumors compared with IDH1 wildtype tumors as a result of dampened expression of the rate-limiting glycolytic enzymes hexokinase and pyruvate kinase [97].